Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 47 TWD 0.21%
Market Cap: 4.2B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note

Maxigen Biotech Inc
Investor Relations

Maxigen Biotech, Inc. engages in the research, development, manufacturing, and sales of biomedical materials and beauty care products. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2011-05-18. The firm operates through two main segments. The Consumer Products segment is mainly engaged in the wholesales of cleansing products, facial care products, medical beauty products and others. The Biomedical Products is mainly involved in the manufacture and sales of Formagraft collagen and ceramic composite material products, Foramic ceramic bone feed materials, Artiaid hyaluronic acid joint injection products, ViscAid ophthalmology viscoelastic agents, as well as SurgiAid wound collagen materials and others.

Show more

Earnings Calls

No Earnings Calls Available

Management

Ms. Ching-Ting Chen
GM & Representative Director
No Bio Available
Ruei Yi Wu
Financial Officer & Accounting Officer
No Bio Available
Ms. Karen Lee
Senior Manager of Administration
No Bio Available

Contacts

Address
TAOYUAN
TAOYUAN
No.88, Keji 1st Road, Guishan District
Contacts
+88633287222
mbi-bio.com